GOLDMAN SACHS GROUP INC - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 77 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q1 2015. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$5,736,000
-61.2%
639,471
-76.8%
0.00%
-60.0%
Q2 2016$14,786,000
+13.1%
2,753,499
-3.1%
0.01%
+25.0%
Q1 2016$13,076,000
-14.8%
2,842,765
-3.7%
0.00%0.0%
Q4 2015$15,347,000
-11.2%
2,951,286
+3.3%
0.00%
-20.0%
Q3 2015$17,291,000
-59.7%
2,857,864
+5.1%
0.01%
-61.5%
Q2 2015$42,943,000
+52.1%
2,719,650
+4.7%
0.01%
+44.4%
Q1 2015$28,238,000
-0.5%
2,597,754
-3.8%
0.01%
+12.5%
Q4 2014$28,393,000
+37.4%
2,698,986
+25.3%
0.01%
+33.3%
Q3 2014$20,657,000
-53.8%
2,154,120
-44.4%
0.01%
-57.1%
Q2 2014$44,758,000
+59.8%
3,875,182
+38.4%
0.01%
+55.6%
Q1 2014$28,008,000
-25.6%
2,800,755
-3.1%
0.01%
-25.0%
Q4 2013$37,643,000
+19608.4%
2,891,155
+22492.4%
0.01%
Q3 2013$191,000
-26.0%
12,797
-53.6%
0.00%
Q2 2013$258,000
+171.6%
27,562
+69.4%
0.00%
Q4 2012$95,000
-12.8%
16,267
-17.0%
0.00%
Q3 2012$109,000
-9.9%
19,610
-9.5%
0.00%
Q2 2012$121,000
+59.2%
21,658
+92.6%
0.00%
Q1 2012$76,00011,2440.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q1 2015
NameSharesValueWeighting ↓
Broadfin Capital, LLC 7,000,000$32,200,0003.11%
SV Health Investors, LLC 888,132$4,085,0003.05%
Sarissa Capital Management LP 2,725,000$12,535,0002.76%
GREAT POINT PARTNERS LLC 1,346,344$6,193,0002.22%
Virtus ETF Advisers LLC 126,869$584,0000.80%
SPHERA FUNDS MANAGEMENT LTD. 400,000$1,840,0000.40%
TFS CAPITAL LLC 459,546$2,114,0000.30%
GLOBEFLEX CAPITAL L P 238,239$1,096,0000.29%
TURNER INVESTMENTS LLC 161,100$741,0000.20%
Birchview Capital, LP 40,000$184,0000.13%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders